Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Artuvet is a specialized biotechnology company focused on veterinary allergy diagnostics and treatment, primarily serving the European market. The company provides comprehensive solutions for identifying and managing environmental allergies in companion animals, including dogs, cats, and horses. Its flagship product line, Artuvetrin, includes advanced serum-based IgE diagnostic tests and customized allergen-specific immunotherapy (ASIT) treatments. Artuvet operates under the Nextmune group, a global leader in companion animal health, and maintains high-standard manufacturing facilities in the Netherlands. The company's mission is to improve the quality of life for pets suffering from chronic dermatological conditions through evidence-based immunological science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artuvet.